CDER help wanted
FDA launches a candidate search for the director position at the Center for Drug Research and Evaluation and will accept applications until Feb. 1, 2008. The job summary does not include mention of the need for the director to mend internal conflicts, which recently led FDA to hire consultants to improve CDER staff interactions (1"The Pink Sheet" Oct. 15, 2007, p. 13). FDA Deputy Commissioner Janet Woodcock is currently serving as acting director...
You may also be interested in...
FDA Hires Consultants To Ease Conflicts Between CDER Staff
FDA is bringing in outside consultants to help improve staff interactions and build leadership in the agency's Center for Drug Evaluation and Research
Podcast: Diversity, Equity, and Inclusion Measures Continue to Evolve in the Clinical Space
Listen to expert perspectives from Tracey Parker, Vice President, Biometrics, Advanced Clinical and Rebecca Starkie, Senior Global Patient Engagement Director, Advanced Clinical on the recent history of DEI in clinical trials and the barriers to patient participation. Examine the key drivers that have influenced the development of diversity, equity, and inclusion programs for clinical trials.
Regeneron, Pfizer Tout Potential BCMA Bispecific Advantages At ASCO
Regeneron presented data for linvoseltamab, while Pfizer presented data for elranatamab, including in patients who previously received BCMA-directed therapy.